Concurrent inhibition of oncogenic and wild-type RAS-GTP for cancer therapy
2024 · Nature · 280 citations
https://doi.org/10.1038/s41586-024-07205-6
Y
Yang Liu
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
3.0K
Papers
50.3K
Citations
89
h-index
1073
i10-index
Yang Liu is an academic researcher from Nanjing University of Chinese Medicine. The author has contributed to research in topics: Cancer-related molecular mechanisms research & MicroRNA in disease regulation & RNA modifications and cancer. The author has an h-index of 89, co-authored 2564 publications.
ORCID: 0000-0002-0367-8189Papers by this author
worksGPX4, ferroptosis, and diseases
2024 · Biomedicine & Pharmacotherapy · 278 citations
https://doi.org/10.1016/j.biopha.2024.116512
Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution
2021 · Nature Communications · 277 citations
https://doi.org/10.1038/s41467-021-21043-4
Aberrant NSUN2-mediated m5C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinoma
2020 · Oncogene · 266 citations
https://doi.org/10.1038/s41388-020-01475-w
TMEM164 is a new determinant of autophagy-dependent ferroptosis
2022 · Autophagy · 161 citations
https://doi.org/10.1080/15548627.2022.2111635
Maternal body mass index and risk of neonatal adverse outcomes in China: a systematic review and meta-analysis
2019 · BMC Pregnancy and Childbirth · 145 citations
https://doi.org/10.1186/s12884-019-2249-z
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat